Methylosystem for cancer sieging strategy

Shotaro Tatekawa, Ken Ofusa, Ryota Chijimatsu, Andrea Vecchione, Keisuke Tamari, Kazuhiko Ogawa, Hideshi Ishii

Research output: Contribution to journalReview articlepeer-review

6 Citations (Scopus)


As cancer is a genetic disease, methylation defines a biologically malignant phenotype of cancer in the association of one-carbon metabolism-dependent S-adenosylmethionine (SAM) as a methyl donor in each cell. Methylated substances are involved in intracellular metabolism, but via intercellular communication, some of these can also be secreted to affect other substances. Although metabolic analysis at the single-cell level remains challenging, studying the “methylosystem” (i.e., the intercellular and intracellular communications of upstream regulatory factors and/or downstream effectors that affect the epigenetic mechanism involving the transfer of a methyl group from SAM onto the specific positions of nucleotides or other metabolites in the tumor microenvironment) and tracking these metabolic products are important research tasks for understanding spatial heterogeneity. Here, we discuss and highlight the involvement of RNA and nicotinamide, recently emerged targets, in SAM-producing one-carbon metabolism in cancer cells, cancer-associated fibroblasts, and immune cells. Their significance and implications will contribute to the discovery of efficient methods for the diagnosis of and therapeutic approaches to human cancer.

Original languageEnglish
Article number5088
Issue number20
Publication statusPublished - Oct 2 2021
Externally publishedYes


  • Cancer-associated fibroblasts
  • Methylation
  • Nicotinamide
  • One-carbon metabolism
  • RNA

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Methylosystem for cancer sieging strategy'. Together they form a unique fingerprint.

Cite this